Adrian Murray Brunt
0000-0002-4797-5097
Publication & Citation Trends
Publications
128 total
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial PDF
Cited by 1,035
OpenAlex
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer PDF
Cited by 286
OpenAlex
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial PDF
Cited by 380
OpenAlex
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial PDF
Cited by 597
OpenAlex
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
Cited by 501
OpenAlex
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial PDF
Cited by 272
OpenAlex
Research Topics
Breast Cancer Treatment Studies
(58)
HER2/EGFR in Cancer Research
(39)
Advanced Breast Cancer Therapies
(30)
Cancer Cells and Metastasis
(22)
Advanced Radiotherapy Techniques
(21)
Affiliations
Institute of Cancer Research
University of Staffordshire
University Hospitals of North Midlands NHS Trust
Peterborough City Hospital
Royal Stoke University Hospital